erasmus critical care days 2011 genetics
TRANSCRIPT
Jan A. Hazelzet, MD PhDPediatric Intensive Care
Sophia Children´s HospitalErasmus Medical Center
Rotterdam, The [email protected]
Genetic Studies in Pediatric Sepsis
Determinants in Infectious Diseases
Microbes
HostEnvirons
Environment
Genetic and environmental influences on premature death in adult adoptees
Sörensen, N Engl J Med 1988; 318: 727-32
Risk of dying was assessed in 960 families for adoptees (born between 1924/26)
Death of a biologic parent before the age of 50 resulted in: RR of death of 1.71 for all
causes
RR of death of 5.81 for infections
Host Response
Eleftherohorinou et al. PLoS One. 2009; 30:e8068
http://www.ornl.gov/hgmis
DNA codes for ~ 80.000 proteins
SNIP = single nucleotide polymorphism
“Equal but not the same”“Equal but not the same”
DNA polymorphism (SNIP, CNP)
Most common type of stable genetic variation 1 of 1000 base pairs (~2.2 million SNPs) Coexistence of 2 different alleles on the same gene location coding for
a certain protein Consequences:
Difference in production of that protein Difference in the protein No consequence
Distribution in the general population 1 % Recently many disease gene associated studies (candidate gene
approach) Haplotype studies
10% =functional
Genetic influences:
risk of developing an infection
severity of diseaseseverity / outcome:
predisposition / susceptibility:
Genetic Influence in Sepsis Studies
Experimental: tissue / cellular
Animals (Knock Outs)
LPS injection volunteers
Patients vs controls
Meningococcal disease
Clinical sepsis
Pneumonia
Trauma / Burns
N. meningitidis
~2000genes
Wright et al. Vaccine 2009; 27S: B90–B102
Genetic polymorphisms are associated with severity (SE) of and susceptibility (SU) for
meningococcal infectionsGene
TLR4
MBL
Properdin
FcRIIa
FcR
PAI-1
Factor V
TNF-
IL-6
IL1β andILRN
Pathway
Innate immunity
Acquired immunity
Coagulation/Fibrinolysis
Cytokines
Polymorphism
rare polymorphisms combinedcodons 52, 54, 57
Combination of 6 SNP’s
HIS 131 ARG
combination of 3 SNPS
4G/5G
G1691A
G-308A
G-174C
- 511C/T+2018T- 511C or C/T + 2018C or C/T
SE/SU
SU
SU
SU SESE SUSU
SESE/OUSE
SEOUSEOUsurvivalsurvival
ODDS ratio
27
5.5 (homozygous)2 (heterozygous)
2504.7 - 15
3.92.72.6
5.92
2.73.11.62.53.12.67.80.6
Lancet Inf Dis 2003; 3:565-77. Cur Opin Infect Dis 2010; 23:255–258
Handling of LPS, PDG,…
Stimulation of the Innate immune system Recognition of pathogen associated molecular patterns (PAMP) by
pathogen recognition proteins: CRP, MBL, C3, PCT, SPA,…. Signal transduction: LBP-CD14-TLR Cytokines, chemokines production Macrophage, granulocyte, lymphocyte, endothelial cell stimulation Complement system Coagulation system Neuro endocrine system …………..
Host responseHost response
TNF as primary cytokine
NEJM 1988; 318: 1481-6
Cytokines in SMD
sepsisseptic shock (surv)septic shock (non-surv)
Intens Care Med 1994; 20: 371-4
Intensive Care Med. 1994 May;20(5):371-4
Variation in the TNF- gene promotor region may be associated with death from meningococcal diseaseVariation in the TNF- gene promotor region may be associated with death from meningococcal disease
TNF-2 allele (G-toA subst. at pos -308) leads to higher inducible levels of TNF-
children with the TNF-2 allele had higher mortality (10/33) vs those without (8/65)
possession of this allele was associated with increased risk of more severe disease (22 of 33) vs (27 of 65)
Nadel et al. J Inf Dis 1996; 174: 878-80
Coagulation in sepsis
Protein C Pathway
Thrombin
PC APCAPC
TM
Endothelial Cell
inhibition offVa and fVIIIa
inhibition ofPAI-1
FIBRINOLYSIS
INFLAMMATION
+PS
COAGULATION
sEPCR
membrane
Prot Creceptor
C4bp
TAFI
sTM• Cytokine production
• Leukocyte adherence
• Apoptosis, etc.
Plasminogen activator inhibitor 1(PAI-1)
Plasminogen activator inhibitor-1 (PAI-1)
50-kDa glycoprotein of the serine protease inhibitor family
Produced by: platelet
endothelial cell
hepatocyt
smooth muscle cell
Acute phase protein (de Boer, 1991)
Triggered by: Inflammatory mediators
(TNF-, IL-1, IL-6, TGF-ß, LPS, VLDL, glucose, glucocorticoids and insulin etc.)
Relation between PAI-1 and TNF- in patients with meningococcal septic shock
Kornelisse, 1996
TNF (pg/ml)1 10 100 1000
PA
I-1 (n
g/m
l)
10
100
1000
10000
NS
S
Kohler, 2000
PAI-1 polymorphisms 9 different polymorphisms have been described Thromb Res 2001; 103: S1-5
3 in the promoter region
Unknown
Many polymorphisms in determinants of PAI-1 like cytokines, insulin etc.
Most extensively studied is 4G/5G polymorphism in the promoter region
PAI-1 promoter polymorphism and outcome of meningococcal sepsis
93 patients with meningococcal sepsis
PAI-1 genotype was significantly related with plasma levels
4G/4G genotype was significantly related to mortality (Hermans, 1999)
500
1,000
1,500
2,000
2,500
3,000
4,4 4,5 5,5
PAI-1 level (ng/ml)
PAI-1 genotype
5G/5G: associated with meningitis4G/4G: associated with sepsis(Westendorp, 1999)
PAI-1 polymorphism related to outcome (Hermans 1999)
4G/4G: associated with increased risk of developing vascular complications and dying from meningococcal disease (Haralambous, 2003)
Host genetic contribution to the risk to develop meningococcal disease (siblings) > one third of the total risk (Haralambous, 2003)
Correlation between 4G/4G and poor outcome (Geishofer 2005)
PAI-1 promoter polymorphism and outcome of meningococcal disease
PAI-1
pro-coagulantmicro particles
APC
Thrombin-TM
t-PA / u-PA
COAGULATION
ANTI-COAGULATION
FIBRINOLYSIS
X
+
-
-
-
endothelial cellsplateletsliver cellsadipocytesmyocytes
metabolic determinantshormonesdietphysical activity
+
+/-
+/-
Host genetics
Environment
X
XX
+
+
+
TNFα/β, IL-1β, IL-6, etc.
Clin Inf Dis 2005; 41 Suppl 7:S453-8
Study of multiple SNP’s
Lancet 2003; 361: 567–71
Nature 2003
Assessment of genetically determined Host Factors Adequate study design Definition of:
Patiënt populations (meningitis vs sepsis, age!) Severity of disease (sepsis vs shock, scores) Subgroups (in- / exclusion) Unknown microbiology
Patiënt numbers (allele frequencies)
Control group (region, socioeconomic status, race)
Ethnic, age, gender differences Interaction or cumulative effects of polymorphisms Clinical relevance (susceptibility or severity, reproducibility) Expensive Limited number of SNP’s are studied at the same moment
• 10 million sequence variants scattered across human genome
• High throughput technology
• Bioinformatic analysis
The way forward…….Genome-Wide Studies
International Meningococcal Disease Genetics Consortium
Mike Levin
Victoria Wright
David Inwald
Simon Nadel
Helen Betts
Lachlan Coin
Harieta Eleftherohorinou
Sonia DavilaMartin Hibberd
Taco KuijpersWillemijn Breunis
Werner ZenzAlexander BinderJan Hazelzet
Marieke Emonts
• Ronald de Groot• Peter Hermans
Enitan Carrol
© Imperial College London
• F. Martinón-Torres
• A. Salas Ellacuriaga
Santiago de Compostela, Spain
International Meningococcal Genetics Consortium
Discovery study
Replication study
Identification of Key Pathways
UK Caucasian MD cases
Validation in European cohort (Austria, Holland, Spain) using Illumina SQNM
Genome-Wide Association Study using Illumina 610 Hap-quad chip
UK Caucasian controls
Bioinformatic Analysis
Top ‘hits’ & selection of candidate genes
Bioinformatic Analysis
Functional Studies Gene Expression/Proteomics
Fine-mapping using Illumina ISelect
Study design
Nat Genet. 2010;42:772-6
Regional association plot of the CFH cluster
CFH cluster on chromosome 1
Hill et al. Clinical Science 2010; 118: 547–564
Negative complement regulators for N Men
TRENDS in Microbiology 2007; 15: 233-40
Future??
www.affymetrix.com
Ultimate Phenotype of the Host Response
Lancet 2004; 363: 2076-83
…function of complex interactions at lower levels…
Conclusions
Differences in host response are genetically determined
SNP’s have been shown to be associated with outcome, but not consistent
Genome-wide SNP genotyping by micro-array technology
Coagulation is an integral part of the immune response
Medical documentation: uniformity – standards (SnoMed) – severity scores, is crucial
Collaboration!!!!! Leads to progress